Safety of Pulmonary Rehabilitation in Acute Exacerbations of Interstitial Lung Disease: A Multicentre Study

View at publisher
Authors: Mitsutoshi Akiho, Yuta Takahashi, Takuya Miyahara, Shuken Kobayashi, Daisuke Minamishima, Yasunari Sakai, Yoshifumi Abe, Takaaki Watanabe, Masahiko Kimura, Naoto Matsumoto, AIR REHAB-ILD Study Collaborators
Cited by: 1
References: 32

Abstract

BACKGROUND AND OBJECTIVE: The safety of pulmonary rehabilitation (PR) during acute exacerbations of interstitial lung disease (AE-ILD) remains uncertain. Utilising a real-world, multicentre clinical context, this study investigated the incidence of PR associated adverse events in hospitalised patients with AE-ILD. METHODS: This multicentre, prospective observational study was conducted over 82 months at five hospitals in Japan. A total of 295 patients with AE-ILD who received PR during hospitalisation were enrolled. Seven types of adverse events were predefined, and their incidence during daily PR sessions was recorded. Patient characteristics, PR content, and clinical outcomes were analysed. RESULTS: < 85% for > 3 min; 79.2%), followed by hypotension (12.5%) and arrhythmia (8.3%). None of the adverse events required additional treatment or prolonged hospitalisation. Patients who experienced adverse events had significantly lower baseline functional status and underwent more PR sessions than those without adverse events. CONCLUSION: PR during AE-ILD was found to be safe when delivered by trained physiotherapists following appropriate risk management procedures. Study findings provide novel evidence supporting the implementation of PR as part of comprehensive care, including during AE-ILD.

Fields of Study & Subjects

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Chronic Obstructive Pulmonary Disease (COPD) Research Inflammatory Myopathies and Dermatomyositis

Publication details

Journal / source
Respirology
Publisher
Wiley
Publication date
28 July 2026
Language
EN